Contrast-enhanced ultrasound for evaluating the pathologic response of breast cancer to neoadjuvant chemotherapy: A meta-analysis

OBJECTIVE: Recent reports have suggested that contrast-enhanced ultrasound (CEUS) can be used to monitor the pathologic responses of breast cancer (BC) to neoadjuvant chemotherapy (NAC); however, the diagnostic performance of CEUS in BC has yet to be confirmed. Thus, we conducted a meta-analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Kun, Li, Li, Wu, Xiao Jing, Hao, Mei Jin, Xue, Hong Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358361/
https://www.ncbi.nlm.nih.gov/pubmed/30681622
http://dx.doi.org/10.1097/MD.0000000000014258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358361/
https://www.ncbi.nlm.nih.gov/pubmed/30681622
http://dx.doi.org/10.1097/MD.0000000000014258

Ejemplares similares